The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Graham Ginger L since year 2005.
The trader's CIK number is 1192601.
At the time of this reporting, Graham Ginger L is the Director of
Amylin Pharmaceuticals Inc
(stock ticker symbol AMLN).
Stock purchases, sales, and option exercises reported by insider Graham Ginger L since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2008-02-04
AMLN
Amylin Pharmaceuticals Inc
Sale
908
31.98
29,040
2007-09-05
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
1,450
19.77
28,666
2007-08-08
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
23,000
13.14
302,296
2007-08-08
AMLN
Amylin Pharmaceuticals Inc
Sale
23,000
51.33
1,180,662
2007-08-06
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
10,000
4.38
43,750
2007-08-07
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
10,000
10.25
102,500
2007-08-06
AMLN
Amylin Pharmaceuticals Inc
Sale
10,000
49.50
495,013
2007-08-07
AMLN
Amylin Pharmaceuticals Inc
Sale
10,000
50.51
505,101
2007-06-12
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
2,898
23.00
66,654
2006-12-05
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
2,173
23.00
49,979
2006-06-09
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
10,869
19.77
214,880
2006-01-05
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
10,000
12.25
122,500
2005-05-06
AMLN
Amylin Pharmaceuticals Inc
Purchase
12,000
16.65
199,799
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Graham Ginger L
(Director of Amylin Pharmaceuticals Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
